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Summary: Childhood absence epilepsy (CAE) is an idiopathic generalised epilepsy (IGE) char-
acterised by typical absence seizures manifested by transitory loss of awareness with 2.5—4Hz
spike-wave complexes on ictal EEG. A genetic component to the aetiology is well recognised but
the mechanism of inheritance and the genes involved are yet to be fully established.
A genome wide single nucleotide polymorphism (SNP)-based high density linkage scan was carried
out using 41 nuclear pedigrees with at least two affected members. Multipoint parametric and
non-parametric linkage analyses were performed using MERLIN 1.1.1 and a susceptibility locus
was identiﬁed on chromosome 3p23-p14 (Zmean = 3.9, p < 0.0001; HLOD= 3.3, ˛ = 0.7). The linked
region harbours the functional candidate genes TRAK1 and CACNA2D2. Fine-mapping using a
tagSNP approach demonstrated disease association with variants in TRAK1.
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Introduction
The absence epilepsies are a group of idiopathic generalised
epilepsies (IGEs) which differ in their seizure frequency, age
of onset and pattern of evolution. A typical absence seizure
manifests as a transitory loss of awareness with 2.5—4Hz
spike-wave complexes on ictal EEG. Many patients also
have generalised tonic—clonic seizures (GTCS), myoclonic
seizures or febrile seizures in addition and a variety of ‘atyp-
ical’ absence seizures are recognised. The International
League Against Epilepsy (ILAE) classiﬁcation recognises a
number of distinct absence epilepsy syndromes including
childhood absence epilepsy (CAE), juvenile absence epilepsy
(JAE), epilepsy with myoclonic absences, juvenile myoclonic
epilepsy (JME) and eyelid myoclonia with absences as a
seizure type (Engel, 2001). However, it is still unclear
whether these syndromes represent a ‘biological continuum’
or distinct entities. Frequency of absence seizures per day
is greater in CAE than JAE, and the occurrence of GTCS is
greater in patients with JAE than CAE. However, there is evi-
dence that CAE and JAE share a close genetic relationship
allowing them to be considered as one phenotype in genetic
studies (Berkovic et al., 1987; Marini et al., 2004).
Twin studies have demonstrated that the IGEs, includ-
ing those in which absence seizures occur, have a signiﬁcant
heritability (Berkovic et al., 1998), with regards to both
occurrence and type of seizure and syndrome with concor-
dance rates for monozygotic twin pairs far higher than for
dizygotic twin pairs (Kjeldsen et al., 2003). Absence epilep-
sies, along with the other common forms of IGE, show a
complex pattern of inheritance. In keeping with other com-
mon genetic disorders, this is expected to result from the
action of a few or many genes of small to moderate effect.
Genome-wide linkage analysis of IGE-multiplex families
has demonstrated evidence for susceptibility loci on chro-
mosomes 2q36, 3q26, and 14q23 (Sander et al., 2000).
Furthermore, loci for three similar forms of absence epilepsy
have been identiﬁed on chromosomes 8q24 (ECA1), 5q31.1
(ECA2) and 3q26 (ECA3) (Fong et al., 1998; Robinson et al.,
2002; Sugimoto et al., 2000; Wallace et al., 2001). We have
previously shown evidence for linkage and association to
chromosome 16p12-p13.1, the region containing the calcium
channel gene CACNG3 (Everett et al., 2007). An association
in humans has been documented between polymorphisms
in CACNA1A (chromosome 19p13.2-p13.1) and IGE includ-
ing CAE (Chioza et al., 2001). Twelve missense mutations in
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CACNA1H (chromosome 16p13.3) have been found in 14 spo-
radic Chinese Han patients with CAE but not in any of 230
unrelated controls (Chen et al., 2003). Mutations in three
GABA receptor genes have been identiﬁed in families with
CAE (sometimes in conjunction with other seizure types):
GABRG2 (Wallace et al., 2001); GABRA1 (Maljevic et al.,
2006); GABRB3 (Feucht et al., 1999; Tanaka et al., 2008).
Four mouse models of spike-wave epilepsy are caused
by mutations in genes for different subunits of voltage-
gated calcium channels (VGCCs): tottering tg, Cacna1a
(Fletcher et al., 1996); lethargic lh, Cacnb4 (Burgess et al.,
1997); stargazer stg, CACNG2 (Letts et al., 1998); ducky
du, Cacna2d2 (Barclay et al., 2001). The du mutation is
a genomic rearrangement resulting in the introduction of
a premature stop codon and predicting the expression of
a truncated protein encoded by the ﬁrst three exons of
Cacna2d2, followed by 8 novel amino acids.
This body of evidence indicates that the majority of idio-
pathic human and animal epilepsies are channelopathies,
with implicated genes likely to be either ion channel genes
or genes for related molecules (see for review Weber and
Lerche, 2008).
The aim of this work was to identify disease-predisposing
loci by undertaking a genome-wide SNP-based linkage scan
using nuclear pedigrees which had at least two affected
members (a proband with CAE and at least one other
non-parental relative with CAE or JAE). A SNP-based
approach provides increased genomic coverage and over-
all provided a greater information content in comparison
to microsatellites (Evans and Cardon, 2004; John et al.,
2004). A ‘‘model-free’’ non-parametric analysis was ini-
tially performed followed by speciﬁc parametric analyses.
Fine-mapping of candidate genes was performed using a
tagSNP approach, combined with re-sequencing of the cod-
ing regions and regulatory regions.
We report here the identiﬁcation of a susceptibility
locus for CAE on chromosome 3 and further analysis of
two positional and functional candidate genes, TRAK1 and
CACNA2D2. Evidence for disease association was shown for
variants in TRAK1 and a putative causal variant has been
investigated.
Materials and methods
Subjects and samples
63 nuclear pedigrees (with a total of 323 individuals; 133 CAE
and 7 JAE cases) and 296 trios (affected child and both parents)
were ascertained from populations with European ancestry includ-
ing the UK, France, Germany, Austria, Greece, The Netherlands,
Denmark, Sweden, Finland, Italy and North America. Appropriate
informed consent was obtained from all participants. Full protocol
and consent form approval was obtained from local research ethics
committees and/or participating institutions as appropriate.
Details of the clinical data on subjects categorised as affected
have been published previously (Everett et al., 2007). Inclusion cri-
teria for CAE, based on the ILAE classiﬁcation, were as follows:
age of onset between 3 and 10 years; normal neurological state
and development; brief and often frequent absence seizures with
abrupt and severe impairment of consciousness; automatisms may
occur; mild myoclonic jerks of the eyes, eyebrows or eyelids may
occur; generalised tonic—clonic seizures may occur; seizures may
persist into adulthood; the ictal EEG shows bilateral, synchronous,
symmetrical discharges of 2.5—4Hz spike-wave complexes on a nor-
mal background or polyspike-wave complexes; photosensitivity may
be present. Exclusion criteria included: signiﬁcant developmental
delay; persistent or focal neurological deﬁcit; clear abnormali-
ties on neuroimaging. Inclusion criteria for JAE were as follows:
age of onset between 10 and 17 years; normal neurological state
and development; brief absence seizures with abrupt and severe
impairment of consciousness occurring sporadically; generalised
tonic—clonic seizures may occur possibly as the initial seizure type;
mild myoclonic jerks may occur; ictal EEG of symmetrical, gener-
alised spike-wave discharges more prominent in the frontal region
at a frequency of 3.5—4.5Hz; photosensitivity may occur. Exclusion
criteria include prominent bilateral myoclonic seizures as occur in
juvenile myoclonic epilepsy.
Genomic DNA was extracted from cheek swab, saliva or blood
samples according to standard kits and protocols (OrageneTM and
Simhelix DNA Isolation kits). 237 of the 304 samples used in
the genome-wide screen were whole genome ampliﬁed (WGA) as
required using the REPLI-g® kit.
Control samples were obtained from the European Collection
of Cell Cultures (ECACC) human random control panels 1, 2 and 3
(HRC-1, HRC-2 and HRC-3; 94 samples per plate). The ECACC HRC
panels include DNA from blood donors who are all UK Caucasians
and are characterised by gender and age at venesection. All donors
have given written informed consent for their blood to be used for
research purposes. Conformation to Hardy—Weinberg Equilibrium
(HWE) was veriﬁed in all SNPs typed in controls.
Genotyping and linkage analysis
Data for linkage analysis was obtained from a successful genome-
wide screen in 240 samples from 41 of the original nuclear pedigrees
(see Supplementary Table 1 for details of these 41 families). A high
failure rate in WGA samples accounts for this loss of data. The
screen was performed using the Illumina Linkage V Panel of 6018
SNPs. Illumina provide a GenCall score for every genotype. This
score is a quality metric that indicates reliability of the genotypes
called with a maximum of 1. Quality control of the data was per-
formed using the GenCall score; a median score of 0.7 was used as
the minimum acceptable value for a SNP to be used and the locus
had to have been successfully typed in both genomic and WGA sam-
ples to be included in analysis. A minimal call rate of 90% was used
leaving 4852 SNPs to be analysed. The average genetic distance
between these SNPs was 0.77 cM and the average physical distance
was 582 kb. There were no signiﬁcant gaps on any chromosome.
Multipoint parametric and non-parametric linkage analyses were
performed using the program MERLIN 1.1.1 (Abecasis et al., 2002)
within the analysis suite EasyLinkage v5.08 (Hoffmann and Lindner,
2005). MERLIN 1.1.1 checks for and removes erroneous genotypes
prior to analysis. Non-parametric Zlr scores were calculated using
the Kong and Cox model (Kong and Cox, 1997) at each SNP loci, along
with its corresponding p-value. The score is compared to a normal
distribution to test for deviation. The assumption of a normal distri-
bution is conservative as are the associated p-values (Whittemore
and Halpern, 1994). Thresholds for suggestive evidence for linkage
and signiﬁcant evidence for linkage were based on those suggested
by Lander and Kruglyak (1995) and are closely comparable. Sug-
gestive linkage is deﬁned by a p-value < 10−3 and the threshold for
signiﬁcant linkage is a p-value < 10−4. These values are equivalent
to one-tailed Z scores of 3.1 and 3.7 respectively, which are them-
selves equivalent to maximised LOD scores of 2.4 and 3.3, which are
the values suggested for genome-wide linkage analysis. Paramet-
ric analysis was performed on those genomic regions which showed
signiﬁcant evidence for linkage using NPL analysis; autosomal dom-
inant inheritance with a penetrance of 50% was assumed. These
parameters correspond to the available data on Mendelian segre-
gation in this trait. They are conservative and the low penetrance
250 B.A. Chioza et al.
reduces the risk of false negative results. A disease allele frequency
of 0.01 and a phenocopy rate of 0.0001 were assumed. These values
are compatible with the observed population prevalence and sibling
recurrence risk ratio attributable to the locus, based on the origi-
nal calculations of Risch (1990). HLOD scores as well as an estimate
of ˛, which represents the proportion of pedigrees consistent with
linkage at a speciﬁc locus, were calculated.
Candidate gene analysis
Knowledge of the underlying pathophysiology of epilepsy is suf-
ﬁciently advanced to allow evaluation of positional candidate
genes within the critical regions according to their expression and
putative function. Information was collected from a number of
human genome resources including the Ensembl, National Center
for Biotechnology Information (NCBI) and University of California-
Santa Cruz (UCSC) Browsers (genome build NCBI36.1), in addition
to the PubMed and Unigene databases. By searching through these
databases, we identiﬁed the most probable functional candidate
genes.
All coding and UTR exons, as well as exon—intron junctions
(sequencing 100 bp either side of each exon), in the best func-
tional candidates, were re-sequenced in 48 affected individuals
from the multiple case pedigrees, using one case from each pedi-
gree. This re-sequencing work was performed by Polymorphic DNA
Technologies Inc., using standard Sanger dideoxy sequencing proto-
cols (http://www.polymorphicdna.com).
Concurrent to the re-sequencing, tagSNPs were designed to
achieve full haplotype coverage of the best functional candidates.
The Tagger program (de Bakker et al., 2005) was run to identify
tagSNPs. The program, using the degree of pair-wise linkage dise-
quilibrium (LD) as measured by a r2 ≥ 0.8 between unassayed and
assayed SNPs in the HapMap (release 21 CEU genotype data), iden-
tiﬁed the SNPs which would capture > 99% of all haplotypes. These
tagSNPs were typed in the entire resource of nuclear pedigrees
and trios and the genotypes were used to construct LD blocks with
Haploview 3.2 (Barrett et al., 2005). Blocks were deﬁned as a solid-
spine of LD, i.e. the ﬁrst and last marker in a block are in strong LD
with all intermediate markers (one slight mismatch is allowed by the
programme), but these intermediate markers are not necessarily in
LD with one another. A minimum D′ of 0.7 was used as the cut-off
point for strong LD. Intrafamilial association analysis was performed
on individual SNPs using the PDT (Martin et al., 2000, 2001, 2003).
The PDT produces two measures of association, the PDT-AVE and the
PDT-SUM. The former gives all families equal weight in the analysis
whereas the latter gives more weight to more informative families.
The same sets of tagSNPs were also genotyped in 282 ECACC
controls and case—control analysis performed using the Pearson’s
chi-squared test or the Fisher Exact Test (when any of the cells in
the calculation table contained a value of 5 or less).
Association analysis of the tagSNPs allowed the identiﬁcation
of gene regions for re-sequencing which would not have been re-
sequenced initially, e.g. intronic areas. The limits for re-sequencing
were determined by the LD structure of the tagSNPs, i.e. re-
sequencing was performed around any associated SNP as far as the
ﬁrst SNPs either side to which it was not in LD. This re-sequencing
was performed in the same 48 cases as exonic re-sequencing was
performed in, by Polymorphic DNA Technologies.
Potential functional effects of identiﬁed variants were assessed
using in silico methods, such as VisualSNP and FastSNP (Yuan et
al., 2006). Standard nucleotide—nucleotide and protein—protein
BLAST searches were performed to assess the degree of conser-
vation across species and therefore to further assess how important
any variant may be functionally.
Figure 1 Multipoint NPL Z scores for all chromosomes. Position refers to genetic distance from the telomere of the short arm of
the chromosome.
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Results
Linkage analysis
The results of the multipoint NPL analysis for each chro-
mosome are shown in Fig. 1. Signiﬁcant evidence for
linkage was found to chromosome 3p22-p14 (NPL Zmax of
3.9, p < 0.0001). The critical region is arbitrarily deﬁned as
extending to where the Z score falls below 3; a region of
approximately 20 cM (Supplementary Table 2). This is a con-
servative approach to deﬁning the critical region so that no
possible candidate genes are overlooked; this region con-
tains 381 genes. Approximately 72% of families, based on
per family Z score, were consistent with linkage to chromo-
some 3. An expanded view of the linked region is shown in
Fig. 2.
Parametric analysis of chromosome 3 demonstrated
signiﬁcant evidence for linkage with a maximum HLOD
(HLODmax) of 3.3 (˛ = 0.7) occurring at 3p21 (Fig. 2).
Candidate gene analysis
Based on reported function, expression patterns and animal
models, we identiﬁed two highly plausible functional candi-
date genes within the chromosome 3p22-p14 linkage region:
TRAK1 and CACNA2D2.
Twenty tagSNPs were typed in CACNA2D2; 31 tagSNPs
were typed in TRAK1. These were selected to encompass
the full possible genomic region covered by the reported
transcripts in the NCBI database (Fig. 3a and b).
Intrafamilial and case—control association analysis of the
CACNA2D2 tagSNPs did not detect any evidence for over-
transmission of any alleles therefore CACNA2D2 was not
analysed further.
Intrafamilial association analysis on the entire resource
detected evidence for overtransmission of the minor allele
Figure 2 NPL Z score and parametric HLOD plots for chro-
mosome 3 for the region showing evidence for linkage; position
refers to genetic distance from the telomere of the short arm
of the chromosome. Each marked point corresponds to a geno-
typed SNP. Chromosome 3 was analysed under the assumption of
autosomal dominant inheritance, assuming a disease allele fre-
quency of 0.01 and a reduced penetrance of 0.5. Also shown,
with red lines, are the approximate positions of two candidate
genes, TRAK1 and CACNA2D2.
to affected offspring in two SNPs in TRAK1 (at the 95% sig-
niﬁcance level; Table 1). The LD block structure of TRAK1 as
predicted using Haploview is shown in Fig. 4. Both disease-
associated SNPs reside in block 2, a 5 kb region of high LD;
therefore it was decided to re-sequence this region at the
same time as the coding regions as part of the re-sequencing
effort. Re-sequencing of this so-called ‘‘associated block’’
was extended to the two ﬂanking SNPs (rs11709411 and
rs9311300; see Figs. 3a and 4) in order to capture all vari-
ants that might be in LD with the associated SNPs in block
2. Re-sequencing of this region (∼5.5 kb) and the coding
exons (and 100 bp either side), the 5′ and 3′ UTR regions,
and 1 kb upstream and downstream of the gene (a total of
∼23.5 kb) identiﬁed 51 known variants and 16 novel variants
(Supplementary Table 3 and Fig. 5). Based on bioinformat-
ics analysis, the variant in TRAK1 which currently seemed to
be the most likely to have a functional effect was a triplet
repeat in the ﬁnal exon of the shorter transcript NM 014965.
The repeat inserts additional glutamic acid residues in a
run of glutamic acid residues and has been reported in the
NCBI SNP database as several different indels; rs10634555,
rs35624871, rs10546421 and rs10530663. The repeat was
therefore genotyped in 96 ECCAC samples to ascertain the
number of alleles and their frequency, and in all the indi-
viduals of the 63 pedigrees to determine any signiﬁcant
association. The ECCAC sample genotyping showed four alle-
les with frequencies: 0.23, 0.24, 0.23 and 0.30. In the 63
probands from the pedigrees, the comparative frequencies
were: 0.23, 0.29, 0.27 and 0.22. However, the results of the
case—control and intrafamilial association analyses were not
statistically signiﬁcant.
Discussion
Childhood absence epilepsy (CAE) is an idiopathic gener-
alised epilepsy (IGE) with a well deﬁned and homogeneous
phenotype that displays a clear electrophysiological hall-
mark and clear evidence of a genetic aetiology. The clinical
criteria adopted here provide the reasonable expectation
that the patients ascertained represent a homogenous clini-
cal phenotype. It is has been shown that IGE phenotypes may
cluster in families with a proband with absence epilepsy,
but analysis reveals an increased clustering of CAE and JAE
(Berkovic et al., 1987; Marini et al., 2004) suggesting that
they may share susceptibility loci. For this reason, pedigrees
in which ﬁrst degree relatives of a proband with CAE had a
diagnosis of JAE were included and such individuals were
categorised as affected (6 of the 63 pedigrees).
We have identiﬁed a novel susceptibility locus for
CAE/JAE on chromosome 3p23-p14 through a SNP-
based genome-wide linkage scan (Zmean = 3.9, p < 0.0001;
HLOD= 3.3, ˛ = 0.7). This is the only region of the genome
for which there is a signiﬁcant linkage score in our analy-
sis. The linkage peaks on chromosomes 9 and 17 which are
close to being statistically suggestive of linkage might war-
rant some attention in future in context of the genetically
complex architecture of IGE syndromes.
The parametric analysis of chromosome 3 indicates that
a large proportion of our pedigrees (∼70%) are consistent
with linkage to chromosome 3p23-p14. We have previously
demonstrated evidence for linkage to 16p12-p13.1, a region
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Figure 3 (a and b) TagSNPs for TRAK1 and CACNA2D2. Underlined SNPs demonstrated evidence for transmission disequilibrium
with intra-familial association analysis using the PDT.
containing the calcium channel gene CACNG3, using a simi-
lar resource of CAE/JAE families (Everett et al., 2007). CAE
is a complex trait and therefore we expect signiﬁcant locus
heterogeneity, with it being quite possible that any family
or individual may have a contribution from more than one
locus. Twenty-one pedigrees are consistent with linkage to
both the 16p12-p13.1 locus and the 3p23-p14 locus identi-
ﬁed in the current study. It is possible that this is suggestive
of interaction between two loci culminating in increased
seizure susceptibility. There is some evidence from mouse
models that different genes can interact and alter seizure
susceptibility. For example, a combination of mutant alleles
in Scn2a and Kcnq2 resulted in a much more severe epilepsy
phenotype than when mutations were only present in a sin-
gle gene (Kearney et al., 2006). This is not something which
we can currently directly test as it requires identiﬁcation of
unambiguous mutations.
Data-mining of this linked region identiﬁed TRAK1 (traf-
ﬁcking protein, kinesin binding) and CACNA2D2 (calcium
channel, voltage dependent, alpha 2/delta subunit 2) as the
most plausible functional candidate genes. Both genes were
investigated with tagSNPs but only variants in TRAK1 demon-
strated signiﬁcant evidence for transmission disequilibrium.
This does not however deﬁnitively exclude CACNA2D2 as
tagSNPs will only detect disease-associated alleles present
at a comparable frequency. It is possible that rare vari-
ants present in a subset of the study population will not
be detected using this methodology.
TRAK1 encodes a trafﬁcking protein originally known as
OIP106 that was initially identiﬁed as a binding partner
for the enzyme -O-linked N-acetylglucosamine (O-GlcNAc)
transferase (Iyer et al., 2003). A homozygous frameshift
mutation in the mouse Trak1 gene, which produces a trun-
cated protein, was found to cause a recessively transmitted
form of hypertonia, a neurological dysfunction characterised
by postural abnormalities, jerky movements, and tremor
(Gilbert et al., 2006). Altered levels of -amino-n-butyric
acid A (GABAA) receptors observed in Trak1 mutant mice
suggested that Trak1 may also participate in the regula-
tion of GABAA receptor endosomal trafﬁcking. The protein
has been shown to interact with the GABAA receptor 1
subunit and it has been hypothesised that Trak1 has a cru-
cial role in regulating the endocytic trafﬁcking of these
receptors and may facilitate the targeting of endocytosed
GABAA receptors back to the cell surface or block them
from degradation (Webber et al., 2008). In the mammalian
central nervous system, GABA is the main inhibitory neuro-
transmitter, activating GABAA receptors (GABAARs) on target
Table 1 Summary of those SNPs in TRAK1 which demonstrated signiﬁcant evidence (p < 0.05 in at least one test statistic) for
overtransmission of the minor allele in the entire resource of 63 pedigrees and 296 trios.
SNP Number transmitted:
number not transmitted
Sum-PDT 2(1df) Z-score p-Value Ave-PDT 
2
(1df) Z-score p-Value
rs9872588 65:41 6 .88 2 .62 0 .009 5.48 2.34 0.019
rs9852952 59:40 5.69 2.39 0.017 4.17 2.04 0.041
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Figure 4 LD structure of TRAK1 based on Haploview analysis of the whole resource. Strong LD is deﬁned as D′ > 0.8. Values for
pairwise D′ (as a percentage) are given in each square except for those where D′ = 1 in which case the square is blank. Level of r2
LD is indicated by the colour of the square; the darker the square, the higher the pairwise r2 value.
Figure 5 Variants found via re-sequencing in TRAK1. ‘‘Known SNPs’’ are those which have previously been identiﬁed and can be
found in the dbSNP database. ‘‘Novel SNPs’’ are those which have not previously been identiﬁed. The ‘‘indel’’ corresponds to the
triplet repeat.
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neurones either in a phasic or a tonic fashion (Farrant and
Nusser, 2005; Mody and Pearce, 2004). GABAA receptors
have been repeatedly documented to play a critical role
in animal models of seizures. The initial GABAA receptor
mutations associated with the idiopathic generalised epilep-
sies were found in the 2 and 1 subunits, consistent with
a genetic defect in phasic, inhibitory GABAergic synaptic
inhibition.
Intrafamilial association analysis identiﬁed two tagSNPs
showing evidence for transmission disequilibrium indicating
disease association. However, re-sequencing of the sur-
rounding region, which includes exon 2 of isoform 1, did
not identify any putative causal variants. There are three
main explanations for this outcome. It is possible that the
association results may both be false positives; although this
is unlikely as intrafamilial association analysis is robust to
artefacts such as population substructure. However, a Bon-
ferroni style correction for multiple testing was not applied
to these analyses because although this would reduce the
risk of type I errors occurring (detection of a false pos-
itive), it would simultaneously have increased the risk of
type II errors (missing any true associations). Thus the asso-
ciation evidence described must be considered as tentative
but requiring independent replication.
A second explanation is that the associated tagSNPs may
be in long-range LD with causal variants not identiﬁed by
the re-sequencing effort (Lawrence et al., 2005). Finally,
it is possible that the two associated tagSNPs are them-
selves causal. It remains very difﬁcult to predict the effect
of intronic variants but that does not mean that they do not
have an effect; it has, for example, been shown that a com-
mon intronic variant in the chemokine receptor gene CXCR3
is associated with gene expression levels and asthma risk
(Choi et al., 2008).
In conclusion, these observations provide genetic evi-
dence of a novel susceptibility locus for childhood absence
epilepsy on chromosome 3p23-p14. Common variants show-
ing transmission disequilibrium have been identiﬁed in the
candidate gene TRAK1. Deﬁnitive evidence to conﬁrm or
exclude this gene will require re-sequencing across an
extended genomic region encompassing TRAK1 in a larger
number of patients and a better understanding of the role
that non-exonic SNPs play in regulation. We have identiﬁed
a large number of novel intronic and 3′ UTR SNPs, the pos-
sible function of which it is currently extremely difﬁcult to
predict. The latter, in particular, may be located within tar-
get sites for miRNA molecules, but information is lacking in
this area and it is not something which we have assessed
in detail. Replication studies in similar resources of CAE
patients are required, and future studies into the biologi-
cal mechanisms of CAE could suggest other candidate genes
in the linked region which would need to be re-sequenced
to identify putative causal variants.
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